VOYA Investment Management
AXSM icon

VOYA Investment Management’s Axsome Therapeutics AXSM Stock Holding History

VOYA Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1M Buy
183,967
+10,666
+6% +$1.84M 0.03% 381
2025
Q4 		$31.7M Buy
173,301
+59,251
+52% +$8.27M 0.03% 406
2025
Q3 		$13.9M Sell
114,050
-25,239
-18% -$2.84M 0.01% 579
2025
Q2 		$14.5M Buy
139,289
+40,289
+41% +$4.27M 0.01% 623
2025
Q1 		$11.5M Sell
99,000
-3,742
-4% -$426K 0.01% 695
2024
Q4 		$8.69M Buy
102,742
+8,259
+9% +$760K 0.01% 784
2024
Q3 		$8.49M Buy
94,483
+2,679
+3% +$234K 0.01% 826
2024
Q2 		$7.39M Buy
91,804
+72,517
+376% +$5.37M 0.01% 851
2024
Q1 		$1.54M Sell
19,287
-2,354
-11% -$198K ﹤0.01% 1445
2023
Q4 		$1.72M Sell
21,641
-34,988
-62% -$2.34M ﹤0.01% 1429
2023
Q3 		$3.96M Buy
56,629
+1,172
+2% +$87.6K ﹤0.01% 1072
2023
Q2 		$3.99M Buy
55,457
+43,294
+356% +$3.19M ﹤0.01% 1075
2023
Q1 		$750K Sell
12,163
-4,199
-26% -$276K ﹤0.01% 1816
2022
Q4 		$1.26M Buy
16,362
+863
+6% +$51.6K ﹤0.01% 1533
2022
Q3 		$692K Buy
15,499
+4,642
+43% +$232K ﹤0.01% 1825
2022
Q2 		$416K Hold
10,857
– – ﹤0.01% 1956
2022
Q1 		$449K Hold
10,857
– – ﹤0.01% 1979
2021
Q4 		$410K Sell
10,857
-445
-4% -$16.4K ﹤0.01% 2128
2021
Q3 		$373K Hold
11,302
– – ﹤0.01% 2219
2021
Q2 		$762K Sell
11,302
-924
-8% -$55.4K ﹤0.01% 1829
2021
Q1 		$692K Buy
12,226
+78
+0.6% +$5.49K ﹤0.01% 1831
2020
Q4 		$990K Buy
12,148
+2,542
+26% +$190K ﹤0.01% 1520
2020
Q3 		$684K Hold
9,606
– – ﹤0.01% 1488
2020
Q2 		$790K Sell
9,606
-3,745
-28% -$288K ﹤0.01% 1388
2020
Q1 		$785K Buy
13,351
+961
+8% +$78.3K ﹤0.01% 1348
2019
Q4 		$1.28M Buy
+12,390
New +$500K ﹤0.01% 1317
2019
Q3 		– Sell
-9,725
Closed -$250K – 2552
2019
Q2 		$250K Buy
+9,725
New +$195K ﹤0.01% 2173

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management's AXSM Position: Q1 2026 in Review

VOYA Investment Management increased its Axsome Therapeutics (AXSM) stake by 6.2% in Q1 2026, buying an estimated $1.84M and bringing the position to 183,967 shares worth $31.1M. The position accounts for 0.03% of the portfolio, ranked #381.

VOYA Investment Management first reported a position in AXSM in Q2 2019 and has held it in 27 quarters since. The position peaked at $31.7M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • VOYA Investment Management held 183,967 shares of Axsome Therapeutics worth $31.1M as of Q1 2026.
  • VOYA Investment Management bought 10,666 Axsome Therapeutics shares in Q1 2026, an estimated $1.84M.
  • Axsome Therapeutics made up 0.03% of VOYA Investment Management's portfolio in Q1 2026, its #381 holding.
  • VOYA Investment Management first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 27 quarters since.
  • VOYA Investment Management's Axsome Therapeutics position peaked at $31.7M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.